Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postpartum Dexamethasone for Class I HELLP Syndrome
NCT00711841Phase 4Terminated
- Sponsor
- IMIP
- Start
- Jul 2011
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone in HELLP syndrome (HELLP), sponsored by IMIP. Started Jul 2011; status: terminated.
02
Drugs
dexamethasone
03
Conditions
HELLP syndrome (HELLP)
Beyond the preview
Go deeper on NCT00711841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00711841.